Literature DB >> 28681538

Prenatal maternal stress events and phenotypic outcomes in Autism Spectrum Disorder.

Kandice J Varcin1, Gail A Alvares1,2, Mirko Uljarević2,3, Andrew J O Whitehouse1.   

Abstract

There is significant heterogeneity amongst individuals with Autism Spectrum Disorder (ASD) in symptom presentation and severity. An understanding of the factors that contribute to and modulate symptom severity are critical to informing prognosis, stratification, and treatment decisions. Maternal prenatal stress exposure is a nonspecific risk factor for a wide array of neurodevelopmental outcomes in subsequent offspring. Emerging evidence suggests that prenatal maternal stress may increase ASD risk and contribute to variability in autism-like traits in the general population. In the current study, we aimed to determine whether prenatal maternal exposure to stressful life events is associated with symptom severity amongst individuals with ASD. We performed multiple regression analyses to examine associations between retrospectively recalled maternal prenatal stressful life events and the severity of ASD-associated symptoms in 174 children with ASD (Mage = 9.09 years; SD = 3.81). ASD-related symptom severity was measured using the Social Responsiveness Scale and communication abilities were measured using the Children's Communication Checklist. Exposure to prenatal stressful life events was a significant predictor of ASD-related symptom severity (t = 2.014; P = .048) and communication abilities (t = -2.925; P = .004) amongst children with ASD, even after controlling for a range of sociodemographic and obstetric variables. Follow-up analyses demonstrated significant increases in symptom severity only in the context of multiple (two or more) prenatal stressful life events. Together, these findings indicate that ASD, in the context of prenatal maternal stress exposure, may be associated with a more severe phenotype, particularly when there are multiple prenatal exposures. Autism Res 2017, 10: 1866-1877.
© 2017 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: There is emerging evidence that prenatal maternal stress may increase the risk for Autism Spectrum Disorder (ASD) and contribute to variability in autism-like traits in the general population. Here, we found that more stressful life events experienced during pregnancy was associated with more severe ASD-related symptoms and poorer communication abilities amongst children with ASD. The results from this study suggest that prenatal maternal stress exposure and its sequelae may contribute to variability in symptom severity amongst children with ASD. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  autism; heterogeneity; maternal stress; prenatal

Mesh:

Year:  2017        PMID: 28681538     DOI: 10.1002/aur.1830

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  11 in total

1.  The Roles of Stress-Induced Immune Response in Female Reproduction.

Authors:  Fang Ma; Ying Feng; Yue Zhang; Ruo-Han Wang; Dongmei Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders.

Authors:  David Q Beversdorf; Hanna E Stevens; Karen L Jones
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

Review 3.  Maternal inflammation and its ramifications on fetal neurodevelopment.

Authors:  Ho-Keun Kwon; Gloria B Choi; Jun R Huh
Journal:  Trends Immunol       Date:  2022-02-05       Impact factor: 16.687

4.  Prenatal stress induced chromatin remodeling and risk of psychopathology in adulthood.

Authors:  Erbo Dong; Subhash C Pandey
Journal:  Int Rev Neurobiol       Date:  2020-09-26       Impact factor: 3.230

Review 5.  Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention.

Authors:  David Q Beversdorf; Hanna E Stevens; Kara Gross Margolis; Judy Van de Water
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.310

6.  Adjusting for allometric scaling in ABIDE I challenges subcortical volume differences in autism spectrum disorder.

Authors:  Camille Michèle Williams; Hugo Peyre; Roberto Toro; Anita Beggiato; Franck Ramus
Journal:  Hum Brain Mapp       Date:  2020-07-30       Impact factor: 5.038

7.  Evaluation of Zn, Cu, and Se Levels in the North American Autism Spectrum Disorder Population.

Authors:  Sunil Q Mehta; Supriya Behl; Patrick L Day; Adriana M Delgado; Nicholas B Larson; Lindsay R Stromback; Andrea R Huebner; Timothy R DeGrado; Jessica M Davis; Paul J Jannetto; Flora Howie; Mukesh K Pandey
Journal:  Front Mol Neurosci       Date:  2021-04-29       Impact factor: 5.639

8.  Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta.

Authors:  Amy Catherine Kelly; Anita Kramer; Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  Clin Sci (Lond)       Date:  2020-12-11       Impact factor: 6.124

9.  Prevalence and characteristics of autistic children attending autism centres in 2 major cities in Saudi Arabia: A cross-sectional study.

Authors:  Heba J Sabbagh; Basma A Al-Jabri; Malek A Alsulami; Lutfi A Hashem; Ala A Aljubour; Rana A Alamoudi
Journal:  Saudi Med J       Date:  2021-04       Impact factor: 1.484

10.  microRNAs and Gene-Environment Interactions in Autism: Effects of Prenatal Maternal Stress and the SERT Gene on Maternal microRNA Expression.

Authors:  David Q Beversdorf; Ayten Shah; Allison Jhin; Janelle Noel-MacDonnell; Patrick Hecht; Bradley J Ferguson; Danielle Bruce; Michael Tilley; Zohreh Talebizadeh
Journal:  Front Psychiatry       Date:  2021-07-05       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.